Tharimmune Presents Positive Clinical Data Highlighting TH104 Metabolic Profile and Advances Program for Prophylaxis Against Ultrapotent Opioid Exposure Following FDA Feedback ...

Lead coordinator of the opioid-free pathway at UPMC Shadyside Heather Margonari says patients can opt out at any time. She said 39 patients have enrolled in the pathway in just over two months.

That was the wake-up call issued Tuesday as the University of Notre Dame hosted an opioid summit called “A Pathway to Hope.” The opioid crisis is ongoing.

By attenuating the burden on hepatic metabolic pathways, TH104 may represent a novel therapeutic candidate for individuals with impaired liver function. The altered pharmacokinetic profile ...